enfortumab vedotin,pembrolizumab
merck,astellas,seagen
[' vedo', 'enfortumab', 'urothelial', 'blcsm', 'pembro']
enfortumab vedotin plus pembrolizumab produces encouraging responses in metastatic urothelial cancer #esmo2022 #blcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.